Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Chicago, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The global stem cell manufacturing market was valued at 24.26 billion in 2024 and is expected to reach US$ 65.49 billion by 2033, growing at a CAGR of 11.96% ...